Common heart attack drug has no benefits and may raise death risk for women, major study finds | Euronews Newsletter Events Loader Newsletter Events Loader Loader Search

Sport

ADVERTISEMENT Beta blockers - drugs long prescribed for post-heart attack care - offer no clear benefit for patients whose hearts pump normally after an uncomplicated myocardial infarction, according to a large international trial. The study also found an increased risk of death and hospitalisation among women who took these drugs. The findings, presented at the European Society of Cardiology congress in Madrid and published simultaneously in The New England Journal of Medicine on Sunday,*